换一批Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
第一作者：
Angela,Bellini
第一单位：
Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.;INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.;SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
作者：
Angela,Bellini [1]
;
Ulrike,Pötschger [2]
;
Virginie,Bernard [3]
;
Eve,Lapouble [4]
;
Sylvain,Baulande [3]
;
Peter F,Ambros [5]
;
Nathalie,Auger [6]
;
Klaus,Beiske [7]
;
Marie,Bernkopf [5]
;
David R,Betts [8]
;
Jaydutt,Bhalshankar [1]
;
Nick,Bown [9]
;
Katleen,de Preter [10]
;
Nathalie,Clément [1]
;
Valérie,Combaret [11]
;
Jaime,Font de Mora [12]
;
Sally L,George [13]
;
Irene,Jiménez [1]
;
Marta,Jeison [14]
;
Barbara,Marques [15]
;
Tommy,Martinsson [16]
;
Katia,Mazzocco [17]
;
Martina,Morini [18]
;
Annick,Mühlethaler-Mottet [19]
;
Rosa,Noguera [20]
;
Gaelle,Pierron [4]
;
Maria,Rossing [21]
;
Sabine,Taschner-Mandl [5]
;
Nadine,Van Roy [10]
;
Ales,Vicha [22]
;
Louis,Chesler [23]
;
Walentyna,Balwierz [24]
;
Victoria,Castel [25]
;
Martin,Elliott [26]
;
Per,Kogner [27]
;
Geneviève,Laureys [28]
;
Roberto,Luksch [29]
;
Josef,Malis [22]
;
Maja,Popovic-Beck [30]
;
Shifra,Ash [31]
;
Olivier,Delattre [32]
;
Dominique,Valteau-Couanet [33]
;
Deborah A,Tweddle [34]
;
Ruth,Ladenstein [35]
;
Gudrun,Schleiermacher [1]
作者单位：
Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.;INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.;SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
[1]
Department for Studies and Statistics and Integrated Research, Vienna, Austria.;St Anna Children's Cancer Research Institute, Vienna, Austria.
[2]
Institut Curie Genomics of Excellence (ICGex) Platform, Research Center, Institut Curie, Paris, France.
[3]
Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France.
[4]
St Anna Children's Cancer Research Institute, Vienna, Austria.
[5]
Service de Génétique des tumeurs; Institut Gustave Roussy, Villejuif, France.
[6]
Department of Pathology, Oslo University Hospital, and Medical Faculty, University of Oslo, Oslo, Norway.
[7]
Department of Clinical Genetics, Children's Health Ireland at Crumlin, Dublin, Ireland.
[8]
Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
[9]
Ghent University, Ghent, Belgium.
[10]
Translational Research Laboratory, Centre Léon Bérard, Lyon, France.
[11]
Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
[12]
Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
[13]
Schneider Children's Medical Center of Israel, Tel Aviv University, Tel Aviv, Israel.
[14]
Departamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal.
[15]
Sahlgrenska University Hospital, Göteborg, Sweden.
[16]
Department of Pathology, IRCCS Istituto Giannina Gaslini, Genova, Italy.
[17]
Laboratory of Molecular Biology, IRCCS Istituto Giannina Gaslini, Genova, Italy.
[18]
Pediatric Hematology-Oncology Research Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
[19]
Department of Pathology, Medical School, University of Valencia-Incliva Health Research Institute/CIBERONC, Madrid, Spain.
[20]
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
[21]
Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
[22]
Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, Sutton, United Kingdom.
[23]
Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
[24]
Clinical and Translational Oncology Research Group, Health Research Institute La Fe, Valencia, Spain.
[25]
Leeds Children's Hospital, Leeds General Infirmary, Leeds, United Kingdom.
[26]
Karolinska University Hospital, Stockholm, Sweden.
[27]
Department of Paediatric Haematology and Oncology, Princess Elisabeth Children's Hospital, Ghent University Hospital, Ghent, Belgium.
[28]
Paediatric Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
[29]
Pediatric Hematology-Oncology Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
[30]
Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
[31]
INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.;SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.;Institut Curie Genomics of Excellence (ICGex) Platform, Research Center, Institut Curie, Paris, France.
[32]
Département d'Oncologie Pédiatrique, Gustave Roussy, Villejuif, France.
[33]
Wolfson Childhood Cancer Research Centre, Newcastle Centre for Cancer, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
[34]
Department for Studies and Statistics and Integrated Research, St Anna Children's Hospital, St Anna Children's Cancer Research Institute, Vienna, Austria.;Department of Paediatrics, Medical University of Vienna, Vienna, Austria.
[35]
主题词
儿童, 学龄前(Child, Preschool);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);欧洲(Europe);女(雌)性(Female);随访研究(Follow-Up Studies);基因扩增(Gene Amplification);人类(Humans);婴儿(Infant);男(雄)性(Male);神经母细胞瘤(Neuroblastoma);预后(Prognosis);随机对照试验(主题)(Randomized Controlled Trials as Topic);危险因素(Risk Factors);存活率(Survival Rate)
DOI
10.1200/JCO.21.00086
PMID
34115544
发布时间
2025-05-30
- 浏览0
Journal of clinical oncology
Journal of clinical oncology
3377-3390页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
